Orexigen Therapeutics, Inc. (OREX) Tops Q2 EPS by 4c
Tweet Send to a FriendGet Alerts OREX Hot Sheet
Price: $6.38 +1.59%
EPS Growth %: -355.6%
Financial Fact:
Net loss per share: -0.21
Today's EPS Names:
CLC, FNSR, MU, More
EPS Growth %: -355.6%
Financial Fact:
Net loss per share: -0.21
Today's EPS Names:
CLC, FNSR, MU, More
Trade OREX Now!
Orexigen Therapeutics, Inc. (NASDAQ: OREX) reported Q2 EPS of ($0.16), $0.04 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $857 thousand versus the consensus estimate of $740 thousand.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- La-Z-boy, Inc. (LZB) Tops Q4 EPS by 5c
- Tough Print Market Leads Tribune to Lower Profits in FY12 (NWSA)
- Coffee Holding Co., Inc. (JVA) Posts Surprise Q2 Loss of 6c/Share
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
